Clevidipine butyrate CAS: 167221-71-8

CAS NO: 167221-71-8
Clevidipine butyrate
Chemical Name: Clevidipine butyrate
Molecular Formula: C21H23Cl2NO6
Formula Weight: 456.32
CAS No.: 167221-71-8
Description Review
Description

Clevidipine butyrate (CAS: 167221-71-8) is a medication that is used to lower blood pressure in patients who have hypertension or high blood pressure. This drug is administered through an IV and works by relaxing the muscles in the walls of blood vessels, which helps to reduce blood pressure.

Chemical name: (±)-2-[2-[3-(2,3-Dihydroxypropyl)-5-methoxy-phenyl]-ethylamino]ethyl 4-(butyryloxy)benzoate

Molecular formula: C27H34N2O7

Formula weight: 510.57 g/mol

CAS No: 167221-71-8

Top ten keywords from Google and Synonyms:

  1. Hypertension
  2. High blood pressure
  3. Antihypertensive drug
  4. Intravenous infusion
  5. Calcium channel blocker
  6. Blood vessels
  7. Vasodilation
  8. Clevidipine injectable emulsion
  9. BP-lowering medication
  10. Coronary artery disease

Synonyms: Clevidipine butyrat, Cleviprex, Clevidipine injectable emulsion

Health benefits of Clevidipine butyrate:

The primary health benefit of Clevidipine butyrate is its ability to lower blood pressure in patients with hypertension or high blood pressure. This drug can help reduce the risk of heart attack, stroke, and other complications related to hypertension.

Potential effects of Clevidipine butyrate:

Clevidipine butyrate works by blocking calcium channels in the walls of blood vessels, which helps to relax those muscles and widen the vessels. As a result, blood pressure is reduced and blood flow is improved, which can help reduce the risk of heart attack, stroke, and other complications related to hypertension.

Product mechanism:

Clevidipine butyrate belongs to a class of drugs known as calcium channel blockers. It works by blocking the influx of calcium ions into the smooth muscle cells of blood vessels, which leads to relaxation of the muscles and dilation of the vessels. This effect helps to reduce blood pressure and improve blood flow.

Safety:

Clevidipine butyrate is generally well-tolerated by patients when used as directed by a healthcare provider. However, like any medication, it does carry some risks and potential side effects. Before taking this medication, patients should discuss their medical history and any current medications with their healthcare provider to ensure that it is safe for them to take.

Side effects of Clevidipine butyrate:

Common side effects of Clevidipine butyrate include headache, nausea, vomiting, and flushing. More serious side effects are rare, but may include allergic reactions, low blood pressure, and irregular heartbeats. Patients who experience any of these symptoms while taking this medication should contact their healthcare provider immediately.

Dosing information:

The recommended dose of Clevidipine butyrate varies depending on the patient's medical history and condition. It is important for patients to follow their healthcare provider's instructions regarding dosing and administration of this medication.

Conclusion:

Clevidipine butyrate is a medication that is used to lower blood pressure in patients with hypertension or high blood pressure. By blocking calcium channels in the walls of blood vessels, this drug can help relax those muscles and widen the vessels, which leads to reduced blood pressure and improved blood flow. While generally considered safe, this medication does carry some risks and potential side effects, so patients should discuss their medical history and any current medications with their healthcare provider before taking it. Overall, Clevidipine butyrate is an effective medication for reducing blood pressure and has the potential to provide many health benefits for patients with hypertension

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code